Japanese Red Cross Kyoto Daini Hospital

Kyoto 602-8026

2 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia, Crohn Disease, Immunoglobulin A Nephropathy, Intracerebral Hemorrhage, Leukemia, Myelomonocytic, Chronic, MDS, Myelodysplastic Syndrome, Myelodysplastic Syndromes, Myeloid Dysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts, Ulcerative Colitis

Studies at this site

• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis — Recruiting now
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia — Completed
• Guadecitabine Extension Study — Stopped early
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) — Stopped early